Hyperinsulinemia in a normal population as a predictor of non-insulin- dependent diabetes mellitus, hypertension, and coronary heart disease: The Barilla Factory revisited

Metabolism: Clinical and Experimental

Volumn 48, Issue 8, 1999, Pages 989-994

  Zavaroni, I ^a   Bonini, L ^a   Gasparini, P ^a   Barilli, A L ^a   Zuccarelli, A ^a   Dall'Aglio, E ^a   Delsignore, R ^a   Reaven, G M ^a  

^a Dept of Int Med and Biomed Sci ^*

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 0032839780     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90195-6     Document Type: Article

References (32)

1. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance N Engl J Med 320:702-706, 1989
2. Fuller JH, Shipley MJ, Rose G, et al: Coronary-heart-disease risk and impaired glucose tolerance: The Whitehall Study. Lancet 1:1373-1376, 1980
3. Vaccaro O, Ruth KJ, Stamler J: Relationship of postload plasma glucose to mortality with 19-yr follow-up. Diabetes Care 13:1328-1334, 1992
4. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 2:131-141, 1979
5. Després J-P, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334-952-957, 1996
6. Kannel WB: Importance of hypertension as a major risk factor in cardiovascular disease, in Genest J, Koiw E, Kuchel O (eds): Hypertension: Physiopathology and Treatment. New York, NY, McGraw-Hill, 1977, pp 888-910
7. Carlson LA, Böttiger LE, Ahfeldt P-E: Risk factors for myocardial infarction in the Stockholm Prospective Study: A 14 year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 206:351-360, 1979
8. Castelli WP, Doyle JT, Gordon T, et al: HDL cholesterol and other lipids in coronary heart disease. Circulation 55:767-772, 1977
9. Miller NE, Thelle DS, Forde OH, et al: The Tromso Heart Study: High-density lipoprotein and coronary artery disease. A prospective case-control study. Lancet 1:965-968, 1978
10. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
11. Ferrannini E, Haffner SM, Mitchell BD, et al: Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 3:416-422, 1991
12. Landin K, Tengvory L, Smith U: Elevated fibrinogen and plasminogen activator (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227:273-278, 1990
13. Haffner SM, Stern MP, Hazuda HP, et al: Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
14. Reaven GM, Chen Y-DI, Jeppesen J, et al: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92:141-146, 1993
15. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34:457-462, 1991
16. Jeppesen J, Hollenbeck CB, Zhou M-Y, et al: Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 15:320-324, 1995
17. Saltin B, Grimby G: Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Circulation 38:1104-1115, 1968
18. Kadish AH, Litle RL, Sterberg JC: A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
19. Hales CN, Randle PJ: Immunoassay of insulin with insulin antibody precipitate. Biochem J 88:137-146, 1963
20. Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, NY, Academic, 1974, pp 1831-1835
21. Allain CC, Poon LS, Richmond W, et al: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
22. Blackburn H: Classification of the electrocardiogram for population studies: Minnesota code. J Electrocardiol 2:305-310, 1969
23. Lopes-Virella HF, Stone P, Ellis S, et al: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
24. Facchini F, Chen Y-DI, Hollenbeck C, et al: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
25. Facchini FS, Riccardo A, Stoohs A, et al: Enhanced sympathetic nervous system activity - The link between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9:1013-1017, 1996
26. Lillioja S, Mott DM, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988-1992, 1993
27. Warram JH, Martin BC, Krolewski AS, et al: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of the diabetic parents. Ann Intern Med 113:909-915, 1990
28. Sicree RA, Zimmet PZ, King HOM, et al: Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36:179-186, 1987
29. Haffner SM, Stern MP, Mitchell BD, et al: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288, 1990
30. Skarfors ET, Lithell HO, Selinus I: Risk factors for the development of hypertension: A 10-year longitudinal study in middle-aged men. J Hypertens 9:217-223, 1991
31. Lissner L, Bengtsson C, Lapidus L, et al: Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20:797-801, 1992
32. Austin MA: Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11:2-14, 1991